Altre lingue Jiangsu Aidea Pharmaceutical Co., Ltd.

Azioni

688488

CNE1000041S6

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
14,07 ^CNY	-3,50%		-14,83%	+12,47%

23/02	Jiangsu Aidea Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Jiangsu Aidea Pharmaceutical Co., Ltd. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Aidea Pharmaceutical, Subsidiaries Get Nod to Trial Anti-HIV Drug	09/01
Aidea Pharmaceutical Unit Scraps Transfer Deal with Lixin Biotechnology for Anti-Tumor Drug	27/12
Aidea Pharmaceutical's HIV Drug Granted Priority Review in China	21/11
China's Drug Regulator Selects Aidea Pharmaceutical's HIV Drug for Priority Review	13/11
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Jiangsu Aidea Applies For 50 Million Yuan Bank Credit	01/09/23
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21/08/23
Aidea Pharma to Apply For 50 Million Yuan Bank Loan	19/06/23
Jiangsu Aidea Pharma to Apply For 60 Million Yuan Bank Loan	25/05/23
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23
Jiangsu Aidea Pharma to Provide Services to China Medicines and Health Products in Three-Year Agreement	23/03/23
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Jiangsu Aidea Pharma Sees Larger Loss in 2022	26/01/23
Jiangsu Aidea Pharma Registers HIV Tablets	06/01/23
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22
Jiangsu Aidea Pharmaceutical Co., Ltd. agreed to acquire 19.9646% stake in Nanjing Nanda Pharmaceutical Co., Ltd. from Jiangsu Sheng Feng Medical Technology Company Limited for CNY 86 million.	19/07/22
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jiangsu Aidea Pharmaceutical Co., Ltd.

Azioni

688488

CNE1000041S6

Altre lingue

Filtri